HIMSHims & Hers Health, Inc.

1. Oct 7, 2026On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the “Company”) as chief accounting officer.Director or officer change · Form 8-K
2. Jul 17, 2026On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.Director or officer change · Form 8-K
3. Jul 1, 2026Receivables Purchase Agreement On July 1, 2026, XeCare LLC and Apostrophe Pharmacy LLC (collectively, the “Sellers”), subsidiaries of Hims & Hers Health, Inc. (the “Company”), entered into a Master Receivables Purchase Agreement (the “RPA”) with JPMorgan Chase Bank, N.A., as purchaser (in such capacity, the …Material agreement entered · Form 8-K
4. Jun 2, 2026On May 29, 2026, Hims & Hers Health, Inc. (the “Company”), as borrower, entered into Amendment No. 3 (the “Amendment”) to the Revolving Credit and Guaranty Agreement, dated as of February 18, 2025 (as amended by that certain Amendment No. 1 to the Revolving Credit and Guaranty Agreement, dated as of June 25, 2025 …Material agreement entered · Form 8-K
5. May 21, 2026Indenture and Notes On May 21, 2026, the Company issued $402.5 million aggregate principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture (the “Indenture”), dated as of May 21, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”)Material agreement entered · Form 8-K
6. May 19, 2026On May 18, 2026, Hims & Hers Health, Inc. (the “Company”) issued a press release relating to its proposed private offering of Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”)Other event · Form 8-K
7. Mar 11, 2026Hims & Hers announces strategic shift for US weight loss business.Regulation FD disclosure · press release
8. Feb 19, 2026On February 19, 2026, Hims & Hers Health, Inc. (the “Company”), Hims, Inc. (the “Guarantor”), and Horizon BidCo Pty Ltd ACN 694 778 375, an Australian proprietary company (the “Purchaser”) and wholly-owned subsidiary of the Company, entered into a Securities Sale Deed (the “Deed”) with the sellers party thereto (the …Material agreement entered · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.